GlycoMimetics (NASDAQ:GLYC – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. Several other equities analysts also recently issued reports on GLYC. StockNews.com downgraded shares of GlycoMimetics from a “hold” rating to a “sell” rating in […]
GlycoMimetics (NASDAQ:GLYC – Get Free Report)‘s stock had its “neutral” rating reiterated by investment analysts at HC Wainwright in a research report issued on Monday, Benzinga reports. Several other research analysts also recently issued reports on the stock. StockNews.com downgraded shares of GlycoMimetics from a “hold” rating to a “sell” rating in a research report […]
Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) have been given an average rating of “Moderate Buy” by the seven brokerages that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 […]
Mach 1 Financial Group LLC reduced its stake in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report) by 35.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 43,828 shares of the biopharmaceutical company’s stock after selling 24,375 shares during the period. […]
Shares of HilleVax, Inc. (NASDAQ:HLVX – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $12.02, but opened at $12.58. HilleVax shares last traded at $11.99, with a volume of 1,768 shares. Analyst Ratings Changes Separately, HC Wainwright reiterated a “buy” rating and issued a $28.00 price […]